ํผ๋ฆฌ๋ ์ (๋นํ๋ฏผ B6)
**ํผ๋ฆฌ๋ ์ (๋นํ๋ฏผ B6)**์ ์๋ง์ ๋์ฌ ๊ณผ์ ์ ํ์์ ์ธ ์์ฉ์ฑ ๋นํ๋ฏผ์ ๋๋ค. ์์ํ์์ ์ฃผ์ ํน์ ์ ์์ฆ์ ์ด์๋์์ง๋(INH) ๋๋ ํฌ๋ฆฌ๋ฏธ๋ ์ค๋ ์ **ํด๋ ์ **๋ก ์ฌ์ฉ๋๊ฑฐ๋, ๋ฆฌํฌ์ ๋ ์๋ฃจ๋น์ (**Doxilยฎ**)๊ณผ ๊ด๋ จ๋ ํผ๋ถ ๋ ์ฑ(์์กฑ์ฆํ๊ตฐ)์ ์ง์ฐ์ํค๋ ๊ฒ์ ๋๋ค. *์์ ํ*: ๊ท ํ ์กํ ์์ ์ฉ ์ฌ๋ฃ๋ฅผ ์ญ์ทจํ๋ ๊ฐ์ ๊ณ ์์ด์์ ์์ด ๊ฒฐํ์ ๊ทนํ ๋๋ฌผ์ง๋ง, ์ฌ๊ฐํ ์์ฅ๊ด ์งํ์ด ์๋ ๊ณ ์์ด๋ ํผ๋ฆฌ๋ ์ ์๊ตฌ๋์ด ์ฆ๊ฐํ ์ ์์ต๋๋ค. ๋ํ, ์ํ๊ด ๋ด ์ฐ๊ตฌ์ ๋ฐ๋ฅด๋ฉด ํผ๋ฆฌ๋ ์ ์ ๊ณ ์์ด ์ ์ ์ข ์์ ์ฑ์ฅ์ ์ต์ ํ ์ ์๋ ๊ฒ์ผ๋ก ๋ํ๋ฌ์ต๋๋ค.
์์ฉ ๊ธฐ์ : Pyridoxine is converted in erythrocytes to **pyridoxal phosphate** and, to a lesser extent, **pyridoxamine**, which act as vital coenzymes for protein, lipid, and carbohydrate utilization. * **Neurotransmitter Synthesis**: Required for the synthesis of **GABA** (gamma-aminobutyric acid) in the CNS, and the conversion of tryptophan โ **serotonin** or niacin. * **Metabolic Pathways**: Essential for glycogen breakdown, heme synthesis, and the conversion of oxalate โ glycine. * **Toxicity Antidote**: Acts as an antidote by directly enhancing the renal excretion of cycloserine and isoniazid.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- To replace pyridoxine antagonized by crimidine ingestion ยท 20 mg/kg ยท IV ยท Once
- Isoniazid (INH) toxicity ยท If quantity of INH ingested is known, give pyridoxine on a mg for mg (1:1) basis. If it is not known, give pyridoxine initially at 71 mg/kg as a 5-10% IV infusion over 30-60 minutes ยท IV ยท Once ยท Some sources say it can be given as an IV bolus. Do not use injectable B-complex vitamins.
- To replace pyridoxine antagonized by crimidine ingestion ยท 20 mg/kg ยท IV ยท Once
- To delay the development of cutaneous toxicity (PPES) associated with doxorubicin containing pegylated liposomes (Doxilยฎ) ยท 50 mg ยท PO ยท q8h (three times daily) ยท During chemotherapy protocol period
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Documented hypersensitivity or sensitivity to pyridoxine
์ด์๋ฐ์
- Paresthesias (reported in humans)
- Somnolence (reported in humans)
- Reduced serum folic acid levels
- Peripheral neuropathy (associated with massive overdoses)
์ฝ๋ฌผ ์ํธ์์ฉ
- Chloramphenicol ยท May cause increased pyridoxine requirements
- Estrogens ยท May cause increased pyridoxine requirements
- Hydralazine ยท May cause increased pyridoxine requirements
- Immunosuppressants (e.g., azathioprine, chlorambucil, cyclophosphamide, corticosteroids) ยท May cause increased pyridoxine requirements
- Isoniazid ยท May cause increased pyridoxine requirements
- Penicillamine ยท May cause increased pyridoxine requirements
- Levodopa ยท Pyridoxine may reduce levodopa efficacy (no interaction when levodopa is used with carbidopa)
- Phenobarbital ยท High dose pyridoxine may decrease phenobarbital serum levels
- Phenytoin ยท High dose pyridoxine may decrease phenytoin serum concentration
๋ชจ๋ํฐ๋ง
- Efficacy for intended use
- Neurologic signs (gait, coordination) if on high doses
๊ณผ์ฉ๋
> **Warning**: While single overdoses are generally not problematic unless massive, chronic high doses can cause severe neurologic toxicity. * **Massive Acute Overdose**: Laboratory animals given 3-4 grams/kg developed seizures and died. * **Chronic Overdose**: Dogs (Beagles) repeatedly given 3 gram oral daily doses developed uncoordinated gait and neurologic signs. Neuronal lesions were noted in sensory, dorsal root ganglia, and trigeminal ganglia. Signs generally resolved over a 2-month drug-free period.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.